IL2 and systemic lupus erythematosus: In conclusion, pharmacological TCR inhibition and IL-2 decreased the Tfh proportion in a murine model of SLE-like cGVHD, and therapeutic use of a combination of tacrolimus and IL-2 efficiently ameliorated proteinuria.